Chwilio Deddfwriaeth

Commission Regulation (EC) No 1024/2009Dangos y teitl llawn

Commission Regulation (EC) No 1024/2009 of 29 October 2009 on the authorisation and refusal of authorisation of certain health claims made on food and referring to the reduction of disease risk and to children’s development and health (Text with EEA relevance)

 Help about what version

Pa Fersiwn

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

Mae hon yn eitem o ddeddfwriaeth sy’n deillio o’r UE

Mae unrhyw newidiadau sydd wedi cael eu gwneud yn barod gan y tîm yn ymddangos yn y cynnwys a chyfeirir atynt gydag anodiadau.Ar ôl y diwrnod ymadael bydd tair fersiwn o’r ddeddfwriaeth yma i’w gwirio at ddibenion gwahanol. Y fersiwn legislation.gov.uk yw’r fersiwn sy’n weithredol yn y Deyrnas Unedig. Y Fersiwn UE sydd ar EUR-lex ar hyn o bryd yw’r fersiwn sy’n weithredol yn yr UE h.y. efallai y bydd arnoch angen y fersiwn hon os byddwch yn gweithredu busnes yn yr UE. EUR-Lex Y fersiwn yn yr archif ar y we yw’r fersiwn swyddogol o’r ddeddfwriaeth fel yr oedd ar y diwrnod ymadael cyn cael ei chyhoeddi ar legislation.gov.uk ac unrhyw newidiadau ac effeithiau a weithredwyd yn y Deyrnas Unedig wedyn. Mae’r archif ar y we hefyd yn cynnwys cyfraith achos a ffurfiau mewn ieithoedd eraill o EUR-Lex. The EU Exit Web Archive legislation_originated_from_EU_p3

Status:

EU_status_warning_original_version
This legislation may since have been updated - see the latest available (revised) version

ANNEX I

PERMITTED HEALTH CLAIMS

Application — Relevant provisions of Regulation (EC) No 1924/2006Applicant — AddressNutrient, substance, food or food categoryClaimConditions of use of the claimConditions and/or restrictions of use of the food and/or additional statement or warningEFSA opinion reference
Article 14(1)(a) health claim referring to a reduction of a disease riskLeaf Int and Leaf Holland, Hoevestein 26, 4903 SC Oosterhout NB, The Netherlands, and Leaf Suomi Oy, PO Box 25, FI-21381 Aura, FinlandChewing gum sweetened with 100 % xylitolChewing gum sweetened with 100 % xylitol has been shown to reduce dental plaque. High content/level of dental plaque is a risk factor in the development of caries in childrenInformation to the consumer that the beneficial effect is obtained with a consumption of 2-3 g of chewing gum sweetened with 100 % xylitol at least 3 times per day after the mealsQ-2008-321
Article 14(1)(b) health claim referring to children’s development and healthDanone SA, C/Buenos Aires, 21, 08029 Barcelona, SpainPhosphorusPhosphorus is needed for the normal growth and development of bone in childrenThe claim can be used only for food which is at least a source of phosphorus as referred to in the claim SOURCE OF [NAME OF VITAMIN/S] AND/OR [NAME OF MINERAL/S] as listed in the Annex to Regulation (EC) No 1924/2006Q-2008-217

ANNEX II

REJECTED HEALTH CLAIMS

Application — Relevant provisions of Regulation (EC) No 1924/2006Nutrient, substance, food or food categoryClaimEFSA opinion reference
Article 14(1)(b) health claim referring to children’s development and healthLactoralLactoral helps to bring back the normal functioning of the alimentary tract during its microflora disturbances (for example in case of loose stools, after taking antibiotics, in case of intestinal disorders caused by enteric pathogens)EFSA-Q-2008-269
Article 14(1)(b) health claim referring to children’s development and healthLactoralLactoral is recommended in order to improve the general immunity by maintaining the microbiological balanceEFSA-Q-2008-477
Article 14(1)(b) health claim referring to children’s development and healthLactoralLactoral helps to protect the alimentary system against enteric pathogens because of strong antagonistic properties and helps to build the natural intestinal barrierEFSA-Q-2008-478
Article 14(1)(b) health claim referring to children’s development and healthLactoralLactoral helps to maintain natural intestinal microflora during travel, changing the climatic zone or a diet, especially in poor hygiene conditionsEFSA-Q-2008-479
Article 14(1)(b) health claim referring to children’s development and healthLactoralLactoral contains living probiotic bacteria with strong ability to intestinal tract colonisation, isolated from healthy, naturally fed infantEFSA-Q-2008-480
Article 14(1)(b) health claim referring to children’s development and healthMumomega®Mumomega® provides the nourishments that support healthy central nervous system developmentEFSA-Q-2008-328
Article 14(1)(b) health claim referring to children’s development and healthEfalex®Efalex® may help maintain coordinationEFSA-Q-2008-121
Article 14(1)(b) health claim referring to children’s development and healthEfalex®Efalex® may help maintain concentrationEFSA-Q-2008-317
Article 14(1)(b) health claim referring to children’s development and healthEfalex®Efalex® may help maintain and support brain development and functionEFSA-Q-2008-318
Article 14(1)(b) health claim referring to children’s development and healthEfalex®Efalex® may help maintain learning abilityEFSA-Q-2008-319
Article 14(1)(b) health claim referring to children’s development and healthEfalex®Efalex® may help maintain and support eye development and functionEFSA-Q-2008-320
Article 14(1)(b) health claim referring to children’s development and healthEye q baby®Eye q baby® provides the nourishments that support healthy central nervous system developmentEFSA-Q-2008-119
Article 14(1)(b) health claim referring to children’s development and healthEye q®Eye q® provides the nourishments that help children to maintain healthy brain functionsEFSA-Q-2008-329
Article 14(1)(b) health claim referring to children’s development and healthEye q®Eye q® provides the nourishments that help children to maintain concentration levelsEFSA-Q-2008-330

Yn ôl i’r brig

Options/Help

Print Options

Close

Mae deddfwriaeth ar gael mewn fersiynau gwahanol:

Y Diweddaraf sydd Ar Gael (diwygiedig):Y fersiwn ddiweddaraf sydd ar gael o’r ddeddfwriaeth yn cynnwys newidiadau a wnaed gan ddeddfwriaeth ddilynol ac wedi eu gweithredu gan ein tîm golygyddol. Gellir gweld y newidiadau nad ydym wedi eu gweithredu i’r testun eto yn yr ardal ‘Newidiadau i Ddeddfwriaeth’.

Gwreiddiol (Fel y’i mabwysiadwyd gan yr UE): Mae'r wreiddiol version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

Dewisiadau Agor

Dewisiadau gwahanol i agor deddfwriaeth er mwyn gweld rhagor o gynnwys ar y sgrin ar yr un pryd

Close

Rhagor o Adnoddau

Gallwch wneud defnydd o ddogfennau atodol hanfodol a gwybodaeth ar gyfer yr eitem ddeddfwriaeth o’r tab hwn. Yn ddibynnol ar yr eitem ddeddfwriaeth sydd i’w gweld, gallai hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted version that was used for the EU Official Journal
  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • pob fformat o’r holl ddogfennau cysylltiedig
  • slipiau cywiro
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill
Close

Rhagor o Adnoddau

Defnyddiwch y ddewislen hon i agor dogfennau hanfodol sy’n cyd-fynd â’r ddeddfwriaeth a gwybodaeth am yr eitem hon o ddeddfwriaeth. Gan ddibynnu ar yr eitem o ddeddfwriaeth sy’n cael ei gweld gall hyn gynnwys:

  • y PDF print gwreiddiol y fel adopted fersiwn a ddefnyddiwyd am y copi print
  • slipiau cywiro

liciwch ‘Gweld Mwy’ neu ddewis ‘Rhagor o Adnoddau’ am wybodaeth ychwanegol gan gynnwys

  • rhestr o newidiadau a wnaed gan a/neu yn effeithio ar yr eitem hon o ddeddfwriaeth
  • manylion rhoi grym a newid cyffredinol
  • pob fformat o’r holl ddogfennau cysylltiedig
  • dolenni i ddeddfwriaeth gysylltiedig ac adnoddau gwybodaeth eraill